On Tuesday, in the course of current trade, Shares of The Coca-Cola Co (NYSE:KO), climbed 1.16%, and is now trading at $41.13.
Coca-Cola, declared a donation of $100,000 to the Hispanic Scholarship Fund (HSF), the nation’s largest not-for-profit organization supporting Hispanic American higher education. In an effort to empower the Hispanic community and to raise additional money for HSF, Coca-Cola is donating $1 for every post on Twitter and Instagram with the hashtag #ForTheDream, up to $10,000.
“Financial pressure is one of the major challenges facing Latinos going to college,” said Alba Adamo, Group Director of Hispanic Marketing at The Coca-Cola Company. “As a community supporter and partner of HSF, Coca-Cola’s #ForTheDream program is assisting provide Hispanic families with the resources needed to go to college and achieve a higher education.”
The Coca-Cola Company, a beverage company, manufactures and distributes various nonalcoholic beverages worldwide. The company primarily offers sparkling beverages and still beverages. Its sparkling beverages comprise nonalcoholic ready-to-drink beverages with carbonation, such as carbonated energy drinks, and carbonated waters and flavored waters.
During an Afternoon trade, Shares of AmerisourceBergen Corp. (NYSE:ABC), climbed 0.39%, and is now trading at $110.52.
AmerisourceBergen Corporation, declared that it plans to release its results for the Third Quarter Fiscal 2015 on Thursday, July 23, 2015 preceding to the opening of trading on the New York Stock Exchange. The Company will host a conference call to talk about the results at 11:00 a.m. Eastern Time on July 23, 2015.
AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally.
Finally, Incyte Corporation (NASDAQ:INCY), gained 4.08% Tuesday, hitting its highest level.
Incyte Corporation, declared that it has planned its second quarter 2015 financial results conference call and webcast for 10:00 a.m. ET on Tuesday, August 4, 2015.
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. It offers JAKAFI, an oral janus associated kinase (JAK) inhibitor for the treatment of patients with intermediate or high-risk myelofibrosis (MF), counting primary MF, post-polycythemia vera MF, and post-essential thrombocythemia MF.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
